Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures?
Academic Article
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- April 1, 2003
has subject area
- 11 Medical and Health Sciences (FoR)
- Cost-Benefit Analysis (MeSH)
- Decision Making (MeSH)
- Formularies as Topic (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Insurance, Pharmaceutical Services (MeSH)
- Ontario (MeSH)
- Pharmaceutical Preparations (MeSH)
- Pharmacy and Therapeutics Committee (MeSH)
published in
- CMAJ Journal